Testing effectiveness (Phase 2)Study completedNCT00146289
What this trial is testing
The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-diabetic, Normotensive Subjects
Who this might be right for
ObesityInsulin Resistance
Boehringer Ingelheim 138